1. Celgene Corporation
2. Roche
3. Merck & Co., Inc.
4. Eli Lilly and Company
5. Amgen Inc.
6. Novartis AG
7. Pfizer Inc.
8. Bristol-Myers Squibb Company
9. AstraZeneca
10. AbbVie Inc.
The competitive landscape in the Pancreatic Cancer Market is fiercely competitive with several key players vying for market share. These companies are constantly striving to develop innovative treatments and therapies to address the unmet medical needs of patients with pancreatic cancer. Additionally, strategic collaborations, acquisitions, and mergers are common practices within the industry as companies seek to strengthen their positions in the market.